How to Treat FSGS with Diffuse Chronic Interstitial Fibrosis

Focal Segmental Glomerulosclerosis (FSGS) refers to the scarring of nephrons. It is a serious pathological category with an unfavorable prognosis. If FSGS is accompanied by diffuse chronic interstitial fibrosis, it can accelerate the deterioration of renal function and may progress into Renal Failure in a short time. Therefore, it is very urgent to treat FSGS along with diffuse chronic interstitial fibrosis.

FSGS is attributable to immune dysfunction. When the pathological FFsubstances like virus, bacteria or other antigens invade into body, they can not defeated by their relevant antibodies. As a result, the antigens and antibodies form complexes in blood and deposit in glomerular epithelial cells. The body initiates inflammation to remove the immune complexes resulting in impairment of epithelial cells.

After the epithelial cells are impaired, it will cause proliferation of extracellular matrix thus causing glomerulosclerosis and interstitial fibrosis.
To treat FSGS along with diffuse chronic interstitial fibrosis, the treatment should focus on clear up immune complexes and extracellular matrix, repairing epithelial cells as well as correcting abnormal immunity. Here immunotherapy is recommended to the patients. Immunotherapy is not a single therapy, but a comprehensive treatment system including western medicines and traditional Chinese medicine.

In immunotherapy, Micro-Chinese Medicine Osmotherapy can degrade the immune deposits and extracellular matrix and make them dissolve in blood. Also, the effective medicine integrants can dilate blood vessels and increase the renal blood supply. Finally, the degraded harmful substances will be passed out into urine through systemic circulation. Also, it can provide a favorable environment for restoring the impaired epithelial cells.  In this way, the renal function will improve greatly and even recover normal.